Skip to main content
Equibles

Bank of New York Mellon Corp

Bank

Position in TNXP — Tonix Pharmaceuticals Holding Corp.

CIK 1390777 NEW YORK, NY
Back to TNXP Full portfolio

Position in TNXP

as of Jun 30, 2026 · filed Aug 6, 2026
Position Value
$532,779
+$114,423 QoQ
Shares Held
41,754
+37.2% QoQ
Ownership
0.243%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#31
of 103 holders
Holding Since
Mar 2021
10 quarters on record
Voting authority Sole 88% Shared 0% None 12%

Common Shares in TNXP Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

Bank of New York Mellon Corp holds $4,864,365,655 across 311 Biotechnology names. TNXP ranks #237 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 VRTX
Vertex Pharmaceuticals Inc / Ma
 1,672,623 $830,842,010
2 REGN
Regeneron Pharmaceuticals, Inc.
 758,492 $472,950,091
3 JAZZ
Jazz Pharmaceuticals plc
 1,578,013 $380,253,782
4 ALNY
Alnylam Pharmaceuticals, Inc.
 492,071 $148,128,128
5 INSM
INSMED Inc
 1,312,756 $139,966,036
6 MRNA
Moderna, Inc.
 1,701,675 $119,168,293
7 RVMD
Revolution Medicines, Inc.
 601,056 $112,565,759
8 INCY
Incyte Corp
 972,825 $110,279,435

All Filings in TNXP

Export CSV
10 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $532,779 41,754
2026-03-31 $418,356 30,426
2025-12-31 $375,878 24,064
2025-09-30 $486,653 20,143
2025-06-30 $638,571 17,748
2022-03-31 $303,904 1,321,327
2021-12-31 $401,723 1,115,899
2021-09-30 $601,998 1,003,331
2021-06-30 $1,071,319 965,153
2021-03-31 $209,683 163,815